Discover the critical bioanalytical factors that influence radiopharmaceutical drug development, from assay design to ...

As RLTs and theranostics gain prevalence, companies must consider how to overcome their associated regulatory, manufacturing ...

It took Virginia Cancer Specialists nearly 1 year to get the supervised case experience needed to fulfill regulation ...

Systemic radioactive medicines as therapies for cancer were first employed in the 1940s, when physicians utilized radioactive iodine for the treatment of thyroid cancer. However, given the lack of ...

Radiopharmaceuticals are drugs that contain, among other ingredients, radioactive forms of chemical elements called radioisotopes. Depending on the type of radiation that those radioisotopes produce, ...

In the fast-growing, ever-evolving world of pharmaceuticals, few sectors are as dynamic and promising as radiopharmaceuticals. Fueled by technological advancements and a growing demand for targeted ...

The world of nuclear medicine is on the cusp of unprecedented advancements powered by the rapid evolution of radiopharmaceuticals. These cutting-edge compounds are redefining how diseases are ...

Medicare Part B IV/RPT administrations rose from 529 (2013) to 12,395 (2023), with diagnostic/interventional radiology leading volume, followed by nuclear medicine, radiation oncology, and medical ...

A renewed interest in radiopharmaceuticals has led to ground-breaking research and improved outcomes in patients with prostate cancer, according to experts. Radiopharmaceuticals have been used to ...